Close Search
JDDonline - Journal of Drugs in Dermatology
  • Home
  • Issues
    • Current Issue
    • eJDD
    • Featured Articles
    • Archived Issues
    • Supplement Library
    • Case Reports
    • Unlocked Access
    • JDD Corner
    • Clinical Solutions
  • Topics
    • Atopic Dermatitis
    • Oats in Skincare
    • Oncoderm
    • Pigmentary Disorders
    • Psoriasis
    • Inclusive Dermatology Atlas
    • Social and Technology
    • Latest News
  • CME
    • CME Activities
  • Multimedia
    • JDD Corner
    • Video Abstracts
    • Podcast
    • Webinars
    • Translational Lecture Series
    • Video Pearls
  • Info
    • About JDD
    • Advertisers
      • Media Kit
      • Podcast Sponsorship
      • Reprints Contact Us
    • Authors
      • Instructions to Authors
      • Submit a Manuscript
      • Author and Peer Review Login
    • Editorial Board
    • Events
    • Contact Editorial
    • Why Publish in the JDD?
    • Institutional, Library, & Corporate Subscriptions
    • Reprints Contact Us
    • SanovaWorks
  • Inclusive Derm Atlas
    • Online Gallery
    • Digital Edition
  • Subscribe Now
  • Log In
  • x-twitter facebook linkedin instagram
Jan 30
Love0

New Insights Into Systemic Drivers of Inflammation and Their Contributions to the Pathophysiology of Acne

By Chuck Lin No Comments
INTRODUCTION Acne vulgaris (AV) is the eighth most prevalent disease globally, and a condition reported to affect at least 50 million people in the United States.1 Because AV affects 80%…
Read More
Jan 30
Love0

What’s Old Is New: An Emerging Focus on Dermatoporosis

By Chuck Lin No Comments
INTRODUCTIONDefined by Kaya and Saurat in 2007, dermatoporosis is a chronic syndrome of excessive skin insufficiency/fragility.1 This loss of the skin's mechanical strength is due to modifications of the extracellular…
Read More
Jan 30
Love0

Sensitive Skin: A Survey of Dermatology Resident Physicians’ Perspectives and Educational Exposures

By Chuck Lin No Comments
INTRODUCTIONSensitive skin (SS) is a subjective syndrome of cutaneous hyperreactivity, characterized by symptoms of redness, itching, burning, tightness, or stinging in response to innocuous stimuli.1,2 SS is common, with an…
Read More
Jan 30
Love0

Benefit of Topical Combination Therapy for Acne: Analyzing Effect Size Using Number Needed to Treat

By Chuck Lin No Comments
INTRODUCTIONAssuming comparable safety and tolerability, patients and healthcare providers strive to choose the most effective treatment for any given condition. For conditions with multiple treatment options, this requires evaluating the…
Read More
Jan 30
Love0

Halobetasol Propionate 0.01% and Tazarotene 0.045% Lotion With a Ceramide-Containing Moisturizer in Adults With Psoriasis

By Chuck Lin No Comments
INTRODUCTIONPsoriasis, a chronic inflammatory disease characterized by erythematous and scaly skin, is caused by hyperproliferation and differentiation of keratinocytes, which results in dysregulation of the skin barrier.1,2 Typically, a healthy…
Read More
Jan 29
Love0

Perceptions, Utilization, and Cost Assessment of Sebaceous Hyperplasia Treatment Modalities: A Pilot Survey

By Chuck Lin No Comments
INTRODUCTIONA recent literature review suggested that the ef fectiveness of sebaceous hyperplasia (SH) treatment was attributed to lesion severity, patient-specific qualities, and cost, rather than a specific treatment modality.1 Ambiguity…
Read More
Jan 28
Love0

FULL SUPPLEMENT: Looking Beyond the Skin, Examining the Patient and Clinician Reported Outcomes and Effects of Acne Vulgaris and Sarecycline Treatment

By Chuck Lin No Comments
In this supplement:Sarecycline Improves Acne Severity, Symptoms, and Psychosocial Burden in Non-nodular Acne Vulgaris: PROSES Study Background: Patient-reported outcomes (PROs) are emerging as a fundamental component of disease impact assessment in…
Read More
Jan 26
Love0

Outcomes for Psoriasis by Self-Identified Racial Groups in Ixekizumab Clinical Trials: A Pooled Analysis

By Chuck Lin No Comments
INTRODUCTIONPsoriasis is a chronic, immune-mediated skin disease affecting approximately 125 million people worldwide, with a higher reported prevalence in the White population (3.6%) than in people with skin of color…
Read More
Jan 26
Love0

The Gastrointestinal Microbiome and Immune Checkpoint Inhibitors: A Review of Human Interventional Studies Among Melanoma Patients

By Chuck Lin No Comments
INTRODUCTIONMelanoma and Immune Checkpoint Inhibitors  Melanoma is a malignant neoplasm of the melanin-producing cells residing in the basal layer of the epidermis.1 Estimations depict 21.5 new cases of cutaneous melanoma…
Read More
Jan 25
Love0

A New Tool to Improve Communication Between Hidradenitis Suppurativa Patients and Health Care Providers

By Chuck Lin No Comments
INTRODUCTIONHidradenitis suppurativa (HS) is a chronic, inflammatory skin condition characterized by abscesses, nodules, fistulae, draining sinus tracts, and scarring.1 Though the pathogenesis of HS is not fully understood, the disease…
Read More
Jan 24
Love0

Tips, Trends, and Truths: A Study of Psoriasis Treatment Content on TikTok

By Chuck Lin No Comments
INTRODUCTIONSocial media is a popular source of medical information.1 Approximately 45% of individuals report that social media plays a role in their decision to seek medical care from a healthcare…
Read More
Jan 24
Love0

Topical Calcineurin Inhibitors in the Management of Chronic Pruritus in Older Adults: A Research Letter

By Chuck Lin No Comments
INTRODUCTIONChronic itch is common among older adults, however, without overt serologic or histologic abnormalities, many geriatric patients have no discernible cause of their pruritus. In these cases, it is postulated…
Read More
« Previous
NextPrevious »

Search page

Advertisement

Popular

  • JDD in the News: Topical Nonsteroidals for Chronic Hand Eczema May 30, 2026
  • Efficacy and Safety of Topical Metformin vs Kligman Formula in the Treatment of Melasma: A Split-Face Study May 29, 2026
  • Longer Pembrolizumab Therapy Reduces Mortality in Stage III and IV Melanoma: A TriNetX Study May 28, 2026
  • Clinical Methodology to Evaluate the Efficacy of a Topical Cosmetic Eye Formulation on the Appearance of Dynamic Periorbital Lines May 27, 2026
  • Safety and Efficacy of Aminolevulinic Acid 20% Topical Solution Activated by Blue Light for Facial Cutaneous Squamous Cell Carcinoma in situ May 26, 2026

Advertisement

News Topics

  • Inclusive Derm Atlas
  • Atopic Dermatitis
  • CME
  • Featured Articles
  • Issue Highlights
  • Oats in Skincare
  • Oncoderm
  • Pigmentary Disorders
  • Psoriasis
  • Skin of Color
CONTACT US     |      FEEDBACK    |      TERMS     |      COOKIE POLICY    |     PRIVACY    |      EDITORIAL POLICY    |     ADVERTISING POLICY  |    MANAGE PREFERENCES  |  YOUR PRIVACY CHOICES

News Topics

  • Inclusive Derm Atlas
  • Atopic Dermatitis
  • CME
  • Featured Articles
  • Issue Highlights
  • Oats in Skincare
  • Oncoderm
  • Pigmentary Disorders
  • Psoriasis
  • Skin of Color
DermAtlas        Derm In-Review         PDE        Next Steps in Derm         Skin of Color Update     ODAC Dermatology, Aesthetic & Surgical Conference LVD        PDE       

Journal of Drugs in Dermatology

  • About Us
  • Contact Us
  • Contact Sales
  • Editorial Board
  • eJDD
  • Institutional, Library, & Corporate Subscriptions
  • Log In
  • Open Access
  • Permissions Request
  • Podcast Sponsorship
  • Subscription Info
  • Store

© 2026 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.

  • twitter
  • facebook
  • linkedin
  • instagram
Close Menu
  • Home
  • Issues
    • Current Issue
    • eJDD
    • Featured Articles
    • Archived Issues
    • Supplement Library
    • Case Reports
    • Unlocked Access
    • JDD Corner
    • Clinical Solutions
  • Topics
    • Atopic Dermatitis
    • Oats in Skincare
    • Oncoderm
    • Pigmentary Disorders
    • Psoriasis
    • Inclusive Dermatology Atlas
    • Social and Technology
    • Latest News
  • CME
    • CME Activities
  • Multimedia
    • JDD Corner
    • Video Abstracts
    • Podcast
    • Webinars
    • Translational Lecture Series
    • Video Pearls
  • Info
    • About JDD
    • Advertisers
      • Media Kit
      • Podcast Sponsorship
      • Reprints Contact Us
    • Authors
      • Instructions to Authors
      • Submit a Manuscript
      • Author and Peer Review Login
    • Editorial Board
    • Events
    • Contact Editorial
    • Why Publish in the JDD?
    • Institutional, Library, & Corporate Subscriptions
    • Reprints Contact Us
    • SanovaWorks
  • Inclusive Derm Atlas
    • Online Gallery
    • Digital Edition
  • Subscribe Now
  • Log In

Search

  • x-twitter
  • facebook
  • linkedin
  • instagram